Axichem Ab Stock Fundamentals
| AXIC-A Stock | SEK 1.24 0.05 4.20% |
aXichem AB fundamentals help investors to digest information that contributes to AXichem AB's financial success or failures. It also enables traders to predict the movement of AXichem Stock. The fundamental analysis module provides a way to measure AXichem AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AXichem AB stock.
AXichem |
aXichem AB Company Shares Outstanding Analysis
AXichem AB's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current AXichem AB Shares Outstanding | 16.54 M |
Most of AXichem AB's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, aXichem AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, aXichem AB has 16.54 M of shares currently outstending. This is 97.31% lower than that of the Basic Materials sector and 94.2% lower than that of the Chemicals industry. The shares outstanding for all Sweden stocks is 97.11% higher than that of the company.
aXichem AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AXichem AB's current stock value. Our valuation model uses many indicators to compare AXichem AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AXichem AB competition to find correlations between indicators driving AXichem AB's intrinsic value. More Info.aXichem AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AXichem AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AXichem AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.AXichem Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AXichem AB's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AXichem AB could also be used in its relative valuation, which is a method of valuing AXichem AB by comparing valuation metrics of similar companies.AXichem AB is currently under evaluation in shares outstanding category among its peers.
AXichem Fundamentals
| Return On Equity | -0.36 | |||
| Return On Asset | -0.17 | |||
| Operating Margin | (7.35) % | |||
| Current Valuation | 224.35 M | |||
| Shares Outstanding | 16.54 M | |||
| Shares Owned By Insiders | 33.21 % | |||
| Shares Owned By Institutions | 17.57 % | |||
| Price To Earning | (26.98) X | |||
| Price To Book | 5.03 X | |||
| Price To Sales | 95.52 X | |||
| Revenue | 4.36 M | |||
| Gross Profit | 909 K | |||
| EBITDA | (12.58 M) | |||
| Net Income | (15.09 M) | |||
| Cash And Equivalents | 39.34 M | |||
| Cash Per Share | 2.62 X | |||
| Total Debt | 164 K | |||
| Debt To Equity | 0.20 % | |||
| Current Ratio | 26.62 X | |||
| Book Value Per Share | 2.62 X | |||
| Cash Flow From Operations | (15.6 M) | |||
| Earnings Per Share | (0.94) X | |||
| Target Price | 57.0 | |||
| Beta | 0.36 | |||
| Market Capitalization | 221.58 M | |||
| Total Asset | 58.77 M | |||
| Retained Earnings | (9 M) | |||
| Working Capital | 5 M | |||
| Current Asset | 5 M | |||
| Net Asset | 58.77 M |
About AXichem AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze aXichem AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AXichem AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of aXichem AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.aXichem AB develops, patents, and markets natural-analogue industrial compounds for the marine, pest control, feed ingredient, and medical application markets in Sweden and internationally. It offers aXiphen-repellent, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables aXiphen-feed ingredient for pig and poultry diets and aXiphen for use in various foods and dietary supplements, as well as in the pharmaceutical industry. aXichem AB is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in AXichem Stock
AXichem AB financial ratios help investors to determine whether AXichem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AXichem with respect to the benefits of owning AXichem AB security.